What’s New

Home What’s New

11

Apr2016

The pCPA Releases First Principles for Subsequent Entry Biologics

On April 1, 2016, the pan-Canadian Pharmaceutical Alliance (pCPA) issued manufacturers a notification of first principles for subsequent entry biologics ... Read More

30

Mar2016

New Implementation Dates for Revisions to the Procedure for Voluntary Withdrawal and Providing CDR Review Team’s Responses

Due to a high workload volume and ensuring submissions are reviewed in a timely manner, CADTH is deferring the effective ... Read More

30

Mar2016

Minimum Period of 120 Calendar Days for Advance Notification of Anticipated Submissions and Resubmissions for CADTH’s CDR and pCODR Programs

Recommendation Framework for CADTH Common Drug Review (CDR) and pan-Canadian Oncology Drug Review (pCODR) Programs In collaboration with the participating jurisdictions ... Read More

24

Mar2016

The PMPRB to Implement Next Steps Regarding the Compendium of Policies, Guidelines and Procedures in June 2016

In December 2015, the Patented Medicine Prices Review Board (PMPRB) posted a Notice and Comment seeking stakeholder comments on ... Read More